Metropolitan Life Insurance CO Ultragenyx Pharmaceutical Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$62.2 - $84.4 $221,058 - $299,957	-3,554 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$73.71 - $87.86 $261,965 - $312,254	3,554 New	3,554 $298,000
Q4 2021 Mar 30, 2023	BUY	$73.71 - $87.86 $25,061 - $29,872	340 Added 10.58%	3,554 $298,000
Q4 2021 Feb 15, 2022	BUY	$73.71 - $87.86 $25,061 - $29,872	340 Added 10.58%	3,554 $299,000
Q3 2021 Jun 21, 2023	BUY	$77.92 - $102.4 $275,992 - $362,700	3,542 New	3,542 $319,000
Q3 2021 Mar 30, 2023	SELL	$77.92 - $102.4 $34,830 - $45,772	-447 Reduced 12.21%	3,214 $289,000
Q3 2021 Nov 15, 2021	SELL	$77.92 - $102.4 $34,830 - $45,772	-447 Reduced 12.21%	3,214 $290,000
Q2 2021 Jun 21, 2023	BUY	$92.19 - $115.71 $337,507 - $423,614	3,661 New	3,661 $349,000
Q2 2021 Mar 30, 2023	SELL	$92.19 - $115.71 $1.23 Million - $1.54 Million	-13,329 Reduced 78.45%	3,661 $349,000
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $335,940 - $421,647	3,644 Added 21435.29%	3,661 $349,000
Q1 2021 Jun 26, 2023	BUY	$106.9 - $167.73 $1.82 Million - $2.85 Million	16,990 New	16,990 $1.93 Billion
Q1 2021 Mar 30, 2023	SELL	$106.9 - $167.73 $63,071 - $98,960	-590 Reduced 3.36%	16,990 $1.93 Million
Q1 2021 May 14, 2021	SELL	$106.9 - $167.73 $1.88 Million - $2.95 Million	-17,563 Reduced 99.9%	17 $1.93 Million
Q4 2020 Jun 22, 2023	BUY	$84.4 - $177.39 $1.48 Million - $3.12 Million	17,580 New	17,580 $2.43 Million
Q4 2020 Mar 30, 2023	BUY	$84.4 - $177.39 $89,379 - $187,856	1,059 Added 6.41%	17,580 $2.43 Million
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $89,379 - $187,856	1,059 Added 6.41%	17,580 $2.43 Million
Q3 2020 Jun 26, 2023	BUY	$72.98 - $90.0 $1.21 Million - $1.49 Million	16,521 New	16,521 $1.36 Million
Q3 2020 Mar 30, 2023	SELL	$72.98 - $90.0 $52,034 - $64,170	-713 Reduced 4.14%	16,521 $1.36 Million
Q3 2020 Nov 13, 2020	SELL	$72.98 - $90.0 $52,034 - $64,170	-713 Reduced 4.14%	16,521 $1.36 Million
Q2 2020 Jun 26, 2023	BUY	$46.91 - $78.22 $808,446 - $1.35 Million	17,234 New	17,234 $1.35 Million
Q2 2020 Mar 30, 2023	BUY	$46.91 - $78.22 $30,303 - $50,530	646 Added 3.89%	17,234 $1.35 Million
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $30,303 - $50,530	646 Added 3.89%	17,234 $1.35 Million
Q1 2020 Jul 12, 2023	BUY	$33.8 - $62.9 $560,674 - $1.04 Million	16,588 New	16,588 $737,000
Q1 2020 Mar 30, 2023	SELL	$33.8 - $62.9 $24,031 - $44,721	-711 Reduced 4.11%	16,588 $737,000
Q1 2020 May 15, 2020	SELL	$33.8 - $62.9 $24,031 - $44,721	-711 Reduced 4.11%	16,588 $737,000
Q4 2019 Jul 12, 2023	BUY	$36.08 - $45.83 $624,147 - $792,813	17,299 New	17,299 $738,000
Q4 2019 Mar 30, 2023	SELL	$36.08 - $45.83 $14,395 - $18,286	-399 Reduced 2.25%	17,299 $738,000
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $14,395 - $18,286	-399 Reduced 2.25%	17,299 $739,000
Q3 2019 Jul 12, 2023	BUY	$42.5 - $63.11 $752,165 - $1.12 Million	17,698 New	17,698 $757,000
Q3 2019 Mar 30, 2023	BUY	$42.5 - $63.11 $44,412 - $65,949	1,045 Added 6.28%	17,698 $757,000
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $44,412 - $65,949	1,045 Added 6.28%	17,698 $757,000
Q2 2019 Jul 12, 2023	BUY	$54.93 - $74.36 $927,822 - $1.26 Million	16,891 New	16,891 $1.07 Million
Q1 2019 Jul 13, 2023	BUY	$39.87 - $69.36 $663,955 - $1.16 Million	16,653 New	16,653 $1.16 Million
Q1 2019 Mar 30, 2023	BUY	$39.87 - $69.36 $663,955 - $1.16 Million	16,653 New	16,653 $1.16 Million
Q1 2019 May 16, 2019	BUY	$39.87 - $69.36 $329,366 - $572,982	8,261 Added 98.44%	16,653 $1.16 Million
Q1 2019 May 15, 2019	SELL	$39.87 - $69.36 $278,810 - $485,034	-6,993 Reduced 45.45%	8,392 $1.43 Million
Q4 2018 Jul 13, 2023	BUY	$38.89 - $77.3 $598,322 - $1.19 Million	15,385 New	15,385 $668,000
Q4 2018 Feb 14, 2019	BUY	$38.89 - $77.3 $468,974 - $932,160	12,059 Added 362.57%	15,385 $669,000
Q3 2018 Jul 13, 2023	BUY	$71.81 - $90.15 $1.09 Million - $1.37 Million	15,187 New	15,187 $1.16 Billion
Q3 2018 Nov 14, 2018	SELL	$71.81 - $90.15 $851,738 - $1.07 Million	-11,861 Reduced 78.1%	3,326 $254,000
Q2 2018 Aug 15, 2018	BUY	$48.54 - $85.31 $50,335 - $88,466	1,037 Added 7.33%	15,187 $0
Q1 2018 May 15, 2018	BUY	$44.33 - $58.52 $65,652 - $86,668	1,481 Added 11.69%	14,150 $0
Q4 2017 Feb 15, 2018	SELL	$43.54 - $57.32 $601,026 - $791,245	-13,804 Reduced 52.14%	12,669 $588,000
Q2 2017 Aug 14, 2017	BUY	N/A	26,473	26,473 $1.64 Million

Others Institutions Holding RARE

# of Institutions

326

Shares Held

85.7M

Call Options Held

520K

Put Options Held

406K

Vanguard Group Inc Valley Forge, PA

9.95M
Shares

$428 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$241 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.12M
Shares

$220 Million
0.91% of portfolio
Wellington Management Group LLP Boston, MA

4.17M
Shares

$179 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.07M
Shares

$132 Million
0.02% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account